Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
meningokok-polysakkarid-vaccine |
Is a |
False |
meningokokvaccine |
Inferred relationship |
Some |
|
Administration of first dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of meningitis C vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of single dose of meningitis C vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
meningokok C-vaccine, konjugeret, injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
meningokok C-vaccine, konjugeret, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
meningokok C-vaccine, konjugeret, injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
meningokok C-vaccine, konjugeret |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of Meningococcus vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Adverse reaction to meningococcal vaccine |
Causative agent |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Meningitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
|
ACWY-vaccination mod meningit |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
meningokok gruppe C-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
meningokok A + C-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
meningokok gruppe A + C + W135 + Y-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Haemophilus influenzae type b + meningokok gruppe C-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
2 |
meningokokvaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
meningokok A, C, W135 og Y-polysaccharidvaccine, injektionsvæske, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
|
meningokok A og C-polysaccharidvaccine injektionsvæske, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
|
Meningitis vaccine ac injection 1 Dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
meningokokvaccine |
Inferred relationship |
Some |
|
Administration of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
2 |
Administration of Meningococcus vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of single dose of meningitis C vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of meningitis C vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
ACWY-vaccination mod meningit |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of first dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
2 |
Administration of single dose of meningitis C vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
ACWY-vaccination mod meningit |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of meningitis C vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of first dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of Meningococcus vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
3 |
Administration of second dose of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
5 |
Administration of first dose of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
5 |
Administration of meningitis C vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
3 |
Administration of meningitis B vaccine |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
3 |
Administration of second dose of vaccine product containing only Neisseria meningitidis serogroup B antigen (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
3 |
Administration of booster dose of vaccine product containing only Neisseria meningitidis serogroup B antigen (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
3 |
Meningococcus group B vaccine |
Is a |
False |
meningokokvaccine |
Inferred relationship |
Some |
|
Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular oligosaccharide conjugated antigens (procedure) |
Direct substance |
False |
meningokokvaccine |
Inferred relationship |
Some |
1 |
Meningococcus group A vaccine |
Is a |
False |
meningokokvaccine |
Inferred relationship |
Some |
|
Meningococcus group C vaccine |
Is a |
False |
meningokokvaccine |
Inferred relationship |
Some |
|
Meningococcus group Y vaccine |
Is a |
False |
meningokokvaccine |
Inferred relationship |
Some |
|